Orlando, FL - ASCO 2009 Annual Meeting: J. A. Ajani discusses Abstract 4511 - Multicenter phase III comparison of cisplatin/S-1 (CS) with cisplatin/5-FU (CF) as first-line therapy in patients with advanced gastric cancer (FLAGS): Secondary and subset analyses. during the Oral Presentation at the American Society for Clinical Oncology Annual Meeting, Monday June 1, 2009. Photo by © ASCO/Todd Buchanan 2009 Technical Questions: email@example.com; Phone: 612-226-5154.
Ajani MDJ. A.